dimarts, 19 de maig del 2015

Medtronic's Q4 sales surge 60% on Covidien buy, outlook narrowed

Medtronic's fiscal 4th-quarter sales surge nearly 60% thanks to its buyout earlier this year of Covidien, prompting the medical device company to tighten its earning forecast.

Medtronic's Q4 sales surge 60% on Covidien buy, outlook raised

read more



from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1R056py

Cap comentari:

Publica un comentari a l'entrada